Targeting TREM2: New Insights into Vestibular Migraine Relief

Research Summary

A recent study published in the Journal of Headache and Pain explores the role of TREM2 in vestibular migraines. Researchers used a rat model to investigate how TREM2 affects central sensitization, a key factor in migraine pathophysiology. They discovered that TREM2 contributes to autophagic dysfunction through the PI3K/Akt/mTOR signaling pathway. This dysfunction may exacerbate migraine symptoms. The study highlights the potential of targeting TREM2 and related pathways as a novel approach to managing vestibular migraines. These findings could pave the way for new therapeutic strategies, although further research is needed to confirm these effects in humans.

Study Details

📄 Title: TREM2 contributes to central sensitization through PI3K/Akt/mTOR-mediated autophagic dysfunction in a rat model of vestibular migraine.

👥 Research Team: Zhang C et al.

📚 Published In: J Headache Pain

📅 Publication Date: 2026 Mar 26

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.